Evolution Of Growth Rate In Children With Growth Retardation Due to Glucocorticosteroid Therapy And Treated By Genotonorm

Evolution Of Growth Rate In Children With Growth Retardation Related To Long-term Corticotherapy And Treated By Genotonorm

To estimate the evolution of height and growth rate over 5 years of growth hormone (GH) treatment To estimate the prognostic factors of growth rate with GH treatment To confirm the good clinical and biological safety of GH treatment in such children

Inclusion Criteria:

• Glucocorticosteroid treatment for 12 months at least
• Bone age < 15 years for a boy and < 13 years for a girl
• Child measured height < - 2 SD, Child currently treated by GH

Exclusion Criteria:

• Known diabetes (type 1 or type 2)
• A previous history of intolerance or hypersensitivity to the study drug or to drugs with similar chemical structures